Prohibitin: a potential therapeutic target in tyrosine kinase signaling

Nature·Dec 15

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research suggests that prohibitin may be a potential therapeutic target in tyrosine kinase signaling. This implies that prohibitin could play a role in the development of new treatments. The potential of prohibitin as a therapeutic target is being explored in relation to its involvement in tyrosine kinase signaling.

Full coverage

Prohibitions in the meta-inflammatory response: a review

Frontiers·May 14

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future

Frontiers·Jun 30

Prohibitin is associated with antioxidative protection in hypoxia/reoxygenation-induced renal tubular epithelial cell injury

Nature·Nov 4

A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression

Frontiers·Jun 30

Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC

Nature·Mar 23

SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy

Frontiers·May 11

Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism

Nature·Dec 11

The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells

Nature·May 15

View original report at Nature ↗

Fetching the latest headlines…